Citation

BibTex format

@article{Hewitt:2022:10.1136/thorax-2022-219068,
author = {Hewitt, RJ and Bartlett, EC and Ganatra, R and Butt, H and Kouranos, V and Chua, F and Kokosi, M and Molyneaux, PL and Desai, SR and Wells, AU and Jenkins, RG and Renzoni, EA and Kemp, S and Devaraj, A and George, PM},
doi = {10.1136/thorax-2022-219068},
journal = {Thorax},
pages = {1149--1151},
title = {Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease},
url = {http://dx.doi.org/10.1136/thorax-2022-219068},
volume = {77},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Interstitial lung abnormalities (ILA) can be incidentally detected in patients undergoing low-dose CT screening for lung cancer. In this retrospective study, we explore the downstream impact of ILA detection on interstitial lung disease (ILD) diagnosis and treatment. Using a targeted approach in a lung cancer screening programme, the rate of de novo ILD diagnosis was 1.5%. The extent of abnormality on CT and severity of lung function impairment, but not symptoms were the most important factors in differentiating ILA from ILD. Disease modifying therapies were commenced in 39% of ILD cases, the majority being antifibrotic therapy for idiopathic pulmonary fibrosis.
AU - Hewitt,RJ
AU - Bartlett,EC
AU - Ganatra,R
AU - Butt,H
AU - Kouranos,V
AU - Chua,F
AU - Kokosi,M
AU - Molyneaux,PL
AU - Desai,SR
AU - Wells,AU
AU - Jenkins,RG
AU - Renzoni,EA
AU - Kemp,S
AU - Devaraj,A
AU - George,PM
DO - 10.1136/thorax-2022-219068
EP - 1151
PY - 2022///
SN - 0040-6376
SP - 1149
TI - Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease
T2 - Thorax
UR - http://dx.doi.org/10.1136/thorax-2022-219068
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000838194900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
UR - https://thorax.bmj.com/content/77/11/1149
UR - http://hdl.handle.net/10044/1/101502
VL - 77
ER -

Publications policy

All members of the Centre should be aware of and follow our MTW Research Publication Policy (PDF).

General enquiries


For any enquiries about the Margaret Turner Warwick Centre for Fibrosing Lung Disease, please contact:

admin.mtwc@imperial.ac.uk